imaging was initially reviewed for size in each case to confirm a diagnosis of pituitary macroadenoma. Age at initial diagnosis, sex, histopathology, and clinical presentation were tabulated.
Preoperative MRI scans were reviewed by a neuroradiologist holding certification of added qualifications for the presence or absence of associated peritumoral cyst(s). Imaging findings were analyzed for tumor size measured in 3 dimensions (craniocaudal [CC] , transverse [T] , and anteroposterior [AP] ), presence and direction of tumor extrasellar extension, tumor shape, presence of intratumoral hemorrhage, and restriction on diffusion-weighted imaging (DWI). Tumor volume was approximated by a modified ellipsoid volume formula (CC×T×AP/2). Peritumoral cysts were examined for signal hyperintensity on T1-and T2-weighted MR images in addition to FLAIR sequences by comparing the measured point value of cyst fluid to CSF within the ventricles. Cyst margins and contents were also evaluated for the presence of enhancement on postcontrast T1-weighted MRI scans. Where available, postoperative MRI scans were also reviewed for resolution of cysts and other postoperative changes. The length of follow-up was determined from clinical records and was defined as time from resection to when the last documented MRI study was performed.
results clinical and histopathological Findings
Twelve patients were identified with giant macroadenomas (≥ 4.0 cm in maximum diameter); 6 patients (3.4%) had macroadenoma-associated peritumoral cysts within our cohort of 179 patients with pituitary macroadenoma. There were 3 female and 3 male patients. Mean age at diagnosis was 39 years (range 25-57 years). All patients were symptomatic at presentation. Four patients presented with symptoms of visual loss, although none had classic bitemporal hemianopsia. Cognitive decline was present in 3 patients, with incontinence secondary to hydrocephalus presenting concomitantly in the single patient with symptomatic hydrocephalus. Two patients presented with headache as a primary symptom. One patient presented with endocrine abnormalities, and 1 patient presented with a CSF leak ( Table 1) .
Three of the 6 patients had null cell adenomas on histopathological analysis. One patient had a mixed adenoma of the lactotrophic/somatotrophic (prolactinoma/growth hormone-secreting) subtype, 1 had a lactotrophic adenoma, and 1 had a mixed gangliocytoma/somatotrophic adenoma, a rare 2-cell type of tumor. Two patients had transsphenoidal resections, whereas 4 patients underwent both transsphenoidal and transcranial procedures. The mean follow-up time was 4.1 years (range 0.5-8.9 years), with 1 patient lost to follow-up (Table 1) .
imaging Findings
All 6 macroadenomas were multilobular in shape and exhibited suprasellar extension; 4 (67%), 5 (83%), and 3 (50%) of the macroadenomas also displayed inferior, anterior, and posterior growth patterns, respectively. Mean CC, T, and AP tumor dimensions were 5.3 cm (range 3.6-7.0 cm), 5.1 cm (range 3.4-7. 4 ). Associated peritumoral cysts had a mean diameter of 2.9 cm (range 0.6-5.8 cm). On imaging, all 6 macroadenomas obstructed or trapped adjacent sulci and fissures, leading to peritumoral cyst formation. Four patients had cysts involving the sylvian fissure, 3 involving the olfactory sulcus, and 1 each involving the suprasellar cistern and interhemispheric fissure. Three pa- tients had solitary peritumoral cysts while the other 3 had 2 or more cysts associated with their tumor (Table 2) . In 4 (67%) of the 6 patients, cyst fluid was hyperintense relative to CSF on T1-and T2-weighted MRI sequences (Fig. 2) . One patient with pituitary apoplexy had hemorrhage into the peritumoral cyst. Five of 6 patients had available FLAIR sequence data; 3 (60%) of 5 patients had hyperintense cystic lesions. In 2 patients, cyst fluid was isointense with CSF on all sequences. None of the peritumoral cyst walls or fluid enhanced with contrast. DWI sequences were available for review in 3 patients, and 1 patient demonstrated restricted diffusion (Table 3) .
Postoperative MRI scans were available in 5 of 6 patients. The peritumoral cysts had completely resolved in 4 patients (80%) and had significantly decreased in size in 1 patient (20%). There were no recurrences or new hyperintensities in any patient (Table 3) .
discussion
There are 2 types of cysts associated with extraaxial CNS neoplasms (e.g., meningioma, schwannoma, craniopharyngioma, and esthesioneuroblastoma): peritumoral and intratumoral. Peritumoral cysts (i.e., tumor-associated cysts) are nonneoplastic cysts that develop at tumor margins. Intratumoral cysts develop within the tumor itself and are usually due to microcystic degeneration, ischemic necrosis, or hemorrhage within the tumor. 1, 5, 16, 22 The pathogenesis of peritumoral cysts is thought to be quite different. Proposed mechanisms include reactive gliosis, peritumoral edema, or trapping of CSF within the cleft between the expanding tumor and adjacent brain. 2, 9, 12, 15, 20, 21 The latter mechanism is the most likely etiology of the cysts in our study.
Elevated protein concentrations (relative to CSF) have been found in the fluid of peritumoral cysts in several studies. 6, [9] [10] [11] We did not evaluate the biochemical composition of peritumoral cystic fluid associated with pituitary macroadenoma and the operating surgeon did not notice a proteinaceous or xanthochromic fluid during the course of resection. All macroadenomas were resected transsphenoidally, either as primary resection or in the initial approach, so observation of the surrounding peritumoral cysts and the response to surgical decompression was not possible. The walls of the cysts were not specifically sampled at the time of surgery; drainage of cysts occurred at the time of the resection as verified on postoperative imaging. The preoperative MRI findings in our cases, however, are consistent with elevated protein concentrations within most of the peritumoral cysts, which were hyperintense on T1-weighted and FLAIR imaging sequences in the majority of our patients. 7, 13 The high prevalence of hyperintensity on T2-weighted images is also consistent with cystic lesions and peritumoral edema. 4, 9 We also observed in the 2 cases with isointense cystic fluid that the CSF flow within these spaces was not completely obstructed, and they continued to communicate to some extent with the ventricles and subarachnoid space. None of our 6 cases showed enhancement on postcontrast MRI scans, which is consistent with previously reported findings and indicates that neither blood-brain barrier disruption nor the tumor itself is the source of the peritumoral cysts. 8, 9 Thus, it is likely that as a juxtatumoral cleft becomes completely trapped, it begins to become more proteinaceous relative to CSF.
In previous studies, entrapment or loculation of CSF was criticized as an improbable mechanism of peritumoral cyst formation in extraaxial tumors, 3, 9, 14 although these studies did not evaluate cysts associated with pituitary macroadenoma. Each tumor in our study demonstrated an anatomical relationship to the surrounding fissures and sulci, indicating that the expanding tumor likely traps CSF in the adjacent cleft. We observed that peritumoral cysts were only associated with macroadenomas that grew to a diameter of at least 4.2 cm in the AP direction. The only macroadenoma less than 4.0 cm in either the CC or T diameters also had reached the maximal AP diameter, 6.8 cm, achieved by any tumor in our study. During our investigation, we identified only 12 patients (7%) with giant macroadenomas (defined as a tumor ≥ 4.0 cm) that were ≥ 4.2 cm in any dimension, the minimum diameter we observed in patients with cysts (data not shown). Six of these patients did not develop cysts, which was likely because of the primarily suprasellar growth pattern with T or AP diameters less than 4.2 cm (Fig. 3) . The 6 cases included in our study also had exclusively multilobular macroadenoma shapes, whereas the other 6 patients had either rounded or "snowman"-shaped tumors. The size and growth pat- tern correlation in our study supports a primary etiology of CSF obstruction in peritumoral cysts associated with pituitary macroadenoma. It is generally believed that resection of the associated neoplasm with evacuation of cyst fluid will decompress and resolve the peritumoral cyst; 9 however, some authors have shown persistence of the cyst despite this method and have postulated that there may be neoplastic meningothelial cells within the cyst wall. 8, 19 Others have reported that cyst walls consist of glial cell proliferation as confirmed by the presence of glial fibrillary acidic protein. 17, 18 In our study, we did not observe any evidence of a cystic capsule, and with no recurrences, it is unlikely that glia play a role in peritumoral cyst formation associated with pituitary macroadenoma. Thus, the cyst itself does not need to be resected or drained if the associated tumor is sufficiently resected to relieve the obstruction. The cyst may actually aid in tumor resection by providing an enhanced cleavage plane to spare normal brain.
conclusions
Peritumoral cysts associated with pituitary macroadenoma are uncommon and previously undescribed in the literature. These cysts are likely nonneoplastic, occur outside of the tumor margins, and should not be mistaken for neoplasm. Here, we report 6 cases that were associated with large macroadenomas that demonstrated extensive anterolateral growth resulting in obstruction of CSF in adjacent brain fissures or sulci. These cysts do not appear to recur or increase in size after surgical decompression and resection of the associated macroadenoma. Peritumoral cysts may aid in resection by functioning as a cleavage plane while resection of the cysts themselves is likely unnecessary.
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